Xylem Inc. logo

Xylem Inc. (XYL)

Market Open
16 Oct, 03:34 PM
NYSE NYSE
$
104. 97
+1.6
+1.5478%
$
23.81B Market Cap
47.02 P/E Ratio
3.15% Div Yield
432,399 Volume
4.14 Eps
$ 103.37
Previous Close
Add Transaction
Day Range
103.41 105.83
Year Range
98.58 154.27
Want to track XYL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Compared to Estimates, Xylem (XYL) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, Xylem (XYL) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 2 years ago
Xylem (XYL) Beats Q2 Earnings and Revenue Estimates

Xylem (XYL) Beats Q2 Earnings and Revenue Estimates

Xylem (XYL) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.98 per share a year ago.

Zacks | 2 years ago
Curious about Xylem (XYL) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Xylem (XYL) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Xylem (XYL) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 2 years ago
Xylem (XYL) Gears Up to Post Q2 Earnings: What to Expect

Xylem (XYL) Gears Up to Post Q2 Earnings: What to Expect

Xylem's (XYL) second-quarter 2024 results are likely to gain from strength across its smart metering and other applications end markets despite weakness in the building solutions end market.

Zacks | 2 years ago
Xylem (XYL) Earnings Expected to Grow: Should You Buy?

Xylem (XYL) Earnings Expected to Grow: Should You Buy?

Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 years ago
Reasons Why Xylem (XYL) Deserves to Be in Your Portfolio

Reasons Why Xylem (XYL) Deserves to Be in Your Portfolio

Xylem (XYL) benefits from strength in the businesses and the acquisition of Evoqua. Its measures to reward shareholders are also encouraging.

Zacks | 2 years ago
What Makes Xylem (XYL) a Strong Momentum Stock: Buy Now?

What Makes Xylem (XYL) a Strong Momentum Stock: Buy Now?

Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 2 years ago